To confirm the altered interaction of pro-death proteins with BCL-XL in the presence of cisplatin we performed an immunoprecipitation of BCL-XL in the two medulloblastoma cell lines following treatment with cisplatin or cisplatin and WEHI-539. This evidence concerns the gene BCL2L1 and medulloblastoma.